PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical company specializing in…
Sanofi Buys US Biopharma Group Blueprint in $9.1 Billion Deal
+ There are no comments
Add yours